previous arrow
next arrow

Mycobacterium Tuberculosis (Emtact) Nosode research

This new therapeutic Nosodede was developed and some research was conducted. It is a new, scientific, and modern version of the Mycobacterium tuberculosis organisms.


  1. A Randomised, Double-Blind Placebo-Controlled, Multi-Centric Clinical Trial of Ultra-Diluted Mycobacterium tuberculosis Nosode (Emtact 30c) in the Management of Recurrent Upper and Lower Respiratory Tract Affections
  2. “Preparation, standardization and in vitro safety testing of Mycobacterium nosodes (Emtact- polyvalent nosode)”, Suvarna Joshi, Sandeepan Mukerjee, Shashikant Vaidya, Gitanjali Talele, Abhay Chowdhary, Rajesh Shah. In Homeopathy; Vol. 105, (2), : April 2016.